815.60美元5.32(0.65%)
2024/12/04更新
績效 / 1月1.04%
3月2.38%
1年22.65%
晨星評等 - 1.現金0.41%
- 2.股票8.56%
- 3.債券0.02%
- 4.其他91.01%
- 1.美國91.02%
- 2.歐洲不包含歐元區4.20%
- 3.歐元區2.78%
- 4.加拿大1.58%
- 1.argenx SE ADR5.93%
- 2.Gilead Sciences Inc4.82%
- 3.Insmed Inc4.14%
- 4.Intra-Cellular Therapies Inc4.02%
- 5.Sarepta Therapeutics Inc3.74%
- 6.Vaxcyte Inc Ordinary Shares3.57%
- 7.Regeneron Pharmaceuticals Inc3.42%
- 8.Alnylam Pharmaceuticals Inc3.16%
- 9.Viking Therapeutics Inc3.13%
- 10.Zealand Pharma AS3.05%
- 1.現金0.41%
- 2.股票8.56%
- 3.債券0.02%
- 4.其他91.01%
- 1.美國91.02%
- 2.歐洲不包含歐元區4.20%
- 3.歐元區2.78%
- 4.加拿大1.58%
- 1.argenx SE ADR5.93%
- 2.Gilead Sciences Inc4.82%
- 3.Insmed Inc4.14%
- 4.Intra-Cellular Therapies Inc4.02%
- 5.Sarepta Therapeutics Inc3.74%
- 6.Vaxcyte Inc Ordinary Shares3.57%
- 7.Regeneron Pharmaceuticals Inc3.42%
- 8.Alnylam Pharmaceuticals Inc3.16%
- 9.Viking Therapeutics Inc3.13%
- 10.Zealand Pharma AS3.05%